Inhibition of the integrin-linked kinase (ILK) pathway represents a novel target in ovarian cancer treatment
| Autor: | Ulm, M.A., Ponnusamy, S., ElNaggar, A.C., Tillmanns, T., Narayanan, R. |
|---|---|
| Zdroj: | In Gynecologic Oncology October 2020 159 Supplement 1:123-123 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect